EP1973872A4 - Inhibitors of histone deacetylase and prodrugs thereof - Google Patents
Inhibitors of histone deacetylase and prodrugs thereofInfo
- Publication number
- EP1973872A4 EP1973872A4 EP07855542A EP07855542A EP1973872A4 EP 1973872 A4 EP1973872 A4 EP 1973872A4 EP 07855542 A EP07855542 A EP 07855542A EP 07855542 A EP07855542 A EP 07855542A EP 1973872 A4 EP1973872 A4 EP 1973872A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prodrugs
- inhibitors
- histone deacetylase
- deacetylase
- histone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/06—Sulfinamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12191995.5A EP2573069A3 (en) | 2006-12-19 | 2007-12-19 | Inhibitors of histone deacetylase and prodrugs thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87076806P | 2006-12-19 | 2006-12-19 | |
PCT/CA2007/002260 WO2008074132A1 (en) | 2006-12-19 | 2007-12-19 | Inhibitors of histone deacetylase and prodrugs thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1973872A1 EP1973872A1 (en) | 2008-10-01 |
EP1973872A4 true EP1973872A4 (en) | 2012-05-09 |
Family
ID=39535930
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07855542A Withdrawn EP1973872A4 (en) | 2006-12-19 | 2007-12-19 | Inhibitors of histone deacetylase and prodrugs thereof |
EP12191995.5A Withdrawn EP2573069A3 (en) | 2006-12-19 | 2007-12-19 | Inhibitors of histone deacetylase and prodrugs thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12191995.5A Withdrawn EP2573069A3 (en) | 2006-12-19 | 2007-12-19 | Inhibitors of histone deacetylase and prodrugs thereof |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1973872A4 (en) |
JP (2) | JP2010513326A (en) |
KR (1) | KR20090094383A (en) |
CN (1) | CN101610996A (en) |
AU (1) | AU2007335216C1 (en) |
CA (1) | CA2672192A1 (en) |
MX (1) | MX2009006542A (en) |
WO (1) | WO2008074132A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008122115A1 (en) * | 2007-04-09 | 2008-10-16 | Methylgene Inc. | Inhibitors of histone deacetylase |
ES2620027T3 (en) | 2008-09-03 | 2017-06-27 | Biomarin Pharmaceutical Inc. | Compositions that include 6-aminohexanoic acid derivatives as HDAC inhibitors |
US8202866B2 (en) * | 2008-09-17 | 2012-06-19 | Hoffmann-La Roche Inc. | Ortho-aminoanilides for the treatment of cancer |
WO2012021982A1 (en) * | 2010-08-20 | 2012-02-23 | Methylgene Inc. | Antifungal agents and uses thereof |
US9233946B2 (en) | 2010-09-17 | 2016-01-12 | Kancera Ab | Sulfonamide compounds |
US20140107166A1 (en) * | 2011-02-14 | 2014-04-17 | Dana-Farber Cancer Institute, Inc. | Histone deacetylase inhibitors and methods of use thereof |
US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
ES2712803T3 (en) | 2011-02-28 | 2019-05-14 | Biomarin Pharm Inc | Histone deacetylase inhibitors |
WO2013041407A1 (en) | 2011-09-19 | 2013-03-28 | Cellzome Ag | Hydroxamic acids as hdac6 inhibitors |
JP2015504056A (en) * | 2011-12-29 | 2015-02-05 | ファーマサイクリックス,インク. | Cinnamic acid hydroxyamide as an inhibitor of histone deacetylase 8 |
US20140081017A1 (en) * | 2012-09-14 | 2014-03-20 | Methylgene Inc. | Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents |
US9562021B2 (en) * | 2013-03-14 | 2017-02-07 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
JP6503338B2 (en) | 2013-03-15 | 2019-04-17 | バイオマリン ファーマシューティカル インコーポレイテッド | HDAC inhibitor |
WO2014138989A1 (en) * | 2013-03-15 | 2014-09-18 | Methylgene Inc. | Method and intermediates for the synthesis of hydroxamic acid compounds |
KR101586045B1 (en) | 2013-07-30 | 2016-01-15 | 충북대학교 산학협력단 | Novel Phenylthiazole-Based Hydroxamic Acids and Anti-Cancer Composition Comprising the Same As Active Ingredient |
US9636298B2 (en) | 2014-01-17 | 2017-05-02 | Methylgene Inc. | Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs |
CN104610166B (en) * | 2015-03-10 | 2017-06-13 | 山东大学 | Pyrimidine benzyl hydroxamic acid histone deacetylases inhibitor and preparation method and application |
CN105237444B (en) * | 2015-09-24 | 2018-03-30 | 沈阳药科大学 | Hydroxamic acid compound and its production and use |
US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
CN107011238B (en) * | 2017-03-14 | 2020-05-01 | 北京化工大学 | Histone deacetylase inhibitor and preparation method and application thereof |
RU2748835C1 (en) * | 2017-11-27 | 2021-05-31 | Совет Научных И Прикладных Исследований | Indol(sulfonil)-n-hydroxybenzamide derivatives as selective hdac inhibitors |
MX2021000395A (en) | 2018-07-11 | 2021-05-12 | Rubedo Life Sciences Inc | Senolytic compositions and uses thereof. |
KR20230155311A (en) | 2022-05-03 | 2023-11-10 | 충북대학교 산학협력단 | Novel N-hydroxypropenamide compound and pharmaceutical composition for preventing or treating cancer comprising the same as an active ingredient |
KR20230155310A (en) | 2022-05-03 | 2023-11-10 | 충북대학교 산학협력단 | Novel N-hydroxypropenamide compound and pharmaceutical composition for preventing or treating cancer comprising the same as an active ingredient |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60112764A (en) * | 1983-11-22 | 1985-06-19 | Ishihara Sangyo Kaisha Ltd | N-benoyl-n'-pyridyloxyphenylurea based compound and insecticide containing the same |
JP2002128769A (en) * | 2000-10-17 | 2002-05-09 | Sumitomo Pharmaceut Co Ltd | Benzothiazin-3-one derivative |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6406688A (en) * | 1964-06-05 | 1965-12-06 | ||
DK172081A (en) | 1980-04-21 | 1981-10-22 | Merck & Co Inc | MERCHANT CONNECTION AND PROCEDURES FOR PRODUCING THEREOF |
JPS5981643A (en) * | 1982-05-06 | 1984-05-11 | Fuji Photo Film Co Ltd | Precursor of developing agent and silver halide photosensitive material containing it |
US4757078A (en) * | 1986-11-28 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents |
US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
US5652355A (en) | 1992-07-23 | 1997-07-29 | Worcester Foundation For Experimental Biology | Hybrid oligonucleotide phosphorothioates |
US5804601A (en) * | 1995-04-10 | 1998-09-08 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamic acid compounds, their production and use |
US5891916A (en) * | 1995-06-21 | 1999-04-06 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamix acid compounds, their production and use |
US6174905B1 (en) * | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
US6545131B1 (en) | 1997-05-19 | 2003-04-08 | The Johns Hopkins University | Tissue specific prodrug |
US7425541B2 (en) | 1998-12-11 | 2008-09-16 | Medarex, Inc. | Enzyme-cleavable prodrug compounds |
DE60011053T2 (en) | 1999-02-18 | 2005-05-25 | SuperGen, Inc., Dublin | PHOSPHOCHOLIN-BOUND PRODRUG DERIVATIVES |
KR20020070285A (en) | 1999-11-23 | 2002-09-05 | 메틸진, 인크. | Inhibitors of histone deacetylase |
US6699899B1 (en) * | 1999-12-21 | 2004-03-02 | Celgene Corporation | Substituted acylhydroxamic acids and method of reducing TNFα levels |
US7115573B2 (en) | 2000-06-14 | 2006-10-03 | Medarex, Inc. | Prodrug compounds with an isoleucine |
US6407235B1 (en) | 2000-08-21 | 2002-06-18 | Hoffmann-La Roche Inc. | Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
US6670344B2 (en) | 2000-09-14 | 2003-12-30 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts |
JP2004359546A (en) * | 2001-03-15 | 2004-12-24 | Ono Pharmaceut Co Ltd | Prophylactic and/or therapeutic agent for solid cancer comprising hydroxamic acid derivative, its nontoxic salt and prodrug substance thereof as active ingredient |
WO2003068242A1 (en) | 2002-02-11 | 2003-08-21 | Vertex Pharmaceuticals Incorporated | Phospholipids as caspase inhibitor prodrugs |
AU2003211362A1 (en) * | 2002-02-21 | 2003-09-09 | Osaka Industrial Promotion Organization | N-hydroxycarboxamide derivative |
EP1583736A1 (en) * | 2003-01-17 | 2005-10-12 | TopoTarget UK Limited | Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
ES2436606T3 (en) * | 2003-03-12 | 2014-01-03 | Celgene Corporation | 7-amido-isoindolyl compounds and their pharmaceutical uses |
KR20100012046A (en) * | 2003-04-07 | 2010-02-04 | 파마시클릭스, 인코포레이티드 | Novel hydroxamates as therapeutic agents |
JP4580932B2 (en) | 2003-06-12 | 2010-11-17 | メルク・シャープ・エンド・ドーム・コーポレイション | Prodrugs of mitotic kinesin inhibitors |
EP1633751A1 (en) * | 2003-06-16 | 2006-03-15 | Chroma Therapeutics Limited | Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
BRPI0414581C1 (en) * | 2003-09-22 | 2021-05-25 | Mei Pharma Inc | compound, pharmaceutical composition comprising said compound and use of said compound |
US20050137141A1 (en) | 2003-10-24 | 2005-06-23 | John Hilfinger | Prodrug composition |
ES2562778T3 (en) * | 2003-12-02 | 2016-03-08 | The Ohio State University Research Foundation | Short chain fatty acids linked to chelating Zn2 + motifs as a novel class of histone deacetylase inhibitors |
EP1541549A1 (en) * | 2003-12-12 | 2005-06-15 | Exonhit Therapeutics S.A. | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods |
CA2561617A1 (en) | 2004-04-05 | 2005-10-20 | Aton Pharma, Inc. | Histone deacetylase inhibitor prodrugs |
US7705017B2 (en) * | 2004-05-03 | 2010-04-27 | En Vivo Pharmaceuticals, Inc. | Compounds for treatment of neurodegenerative diseases |
US20080015190A1 (en) * | 2004-07-12 | 2008-01-17 | Chakravarty Prasun K | Inhibitors of Histone Deacetylase |
US20080248506A1 (en) * | 2004-10-07 | 2008-10-09 | Pharmacyclics, Inc. | Method of Monitoring Anti-Tumor Activity of an Hdac Inhibitor |
EP1841747B1 (en) * | 2005-01-14 | 2012-09-05 | SK Biopharmaceuticals Co., Ltd. | Oxazole hydroxamic acid derivatives and use thereof |
WO2006099416A1 (en) * | 2005-03-11 | 2006-09-21 | Nitromed, Inc. | 2-methyl indole cyclooxygenase-2 selective inhibitors, compositions and methods of use |
AU2006327892B2 (en) * | 2005-12-19 | 2011-12-22 | Methylgene Inc. | Histone deacetylase inhibitors for enhancing activity of antifungal agents |
CA2660163A1 (en) * | 2006-08-11 | 2008-02-21 | Methylgene Inc. | Potentiation of antifungal compounds |
-
2007
- 2007-12-19 AU AU2007335216A patent/AU2007335216C1/en not_active Ceased
- 2007-12-19 CA CA002672192A patent/CA2672192A1/en not_active Abandoned
- 2007-12-19 JP JP2009541704A patent/JP2010513326A/en active Pending
- 2007-12-19 KR KR1020097015215A patent/KR20090094383A/en not_active Application Discontinuation
- 2007-12-19 WO PCT/CA2007/002260 patent/WO2008074132A1/en active Application Filing
- 2007-12-19 MX MX2009006542A patent/MX2009006542A/en not_active Application Discontinuation
- 2007-12-19 EP EP07855542A patent/EP1973872A4/en not_active Withdrawn
- 2007-12-19 EP EP12191995.5A patent/EP2573069A3/en not_active Withdrawn
- 2007-12-19 CN CNA2007800515415A patent/CN101610996A/en active Pending
-
2014
- 2014-01-17 JP JP2014006984A patent/JP2014111615A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60112764A (en) * | 1983-11-22 | 1985-06-19 | Ishihara Sangyo Kaisha Ltd | N-benoyl-n'-pyridyloxyphenylurea based compound and insecticide containing the same |
JP2002128769A (en) * | 2000-10-17 | 2002-05-09 | Sumitomo Pharmaceut Co Ltd | Benzothiazin-3-one derivative |
Non-Patent Citations (11)
Title |
---|
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; "Insecticidal N-benzoyl-N-pyridyloxyphenylureas", XP002672210, retrieved from STN Database accession no. 1986:5782 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; DELIWALA, C. V. ET AL: "Chemotherapy of tuberculosis. V. Synthesis of some N4-acyl-N1-arylsulfanilhydroxamides", XP002672208, retrieved from STN Database accession no. 1951:36112 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MOORE, MAURICE L. ET AL: "Substituted sulfanilamides. III. N4-Acyl-N1-hydroxy derivatives", XP002672209, retrieved from STN Database accession no. 1940:43200 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SAMIZO, FUMIO ET AL: "Preparation of benzothiazin-3-ones as matrix metalloprotease inhibitors and prodrugs for treatment of joint disease, cancer metastasis, inflammation and periodontitis", XP002672211, retrieved from STN Database accession no. 2002:344919 * |
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ECKSTEIN, ZYGMUNT: "Synthesis of 6-methoxybenzoxazolone", XP002672207, retrieved from STN Database accession no. 1962:456227 * |
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; GUILLAUMEL, JEAN ET AL: "Synthesis of 3-chloroindolinones from variously substituted .beta.-nitrostyrenes", XP002672206, retrieved from STN Database accession no. 1981:424707 * |
DELIWALA, C. V. ET AL: "Chemotherapy of tuberculosis. V. Synthesis of some N4-acyl-N1-arylsulfanilhydroxamides", PROCEEDINGS - INDIAN ACADEMY OF SCIENCES, SECTION A , 31A, 183-6 CODEN: PISAA7; ISSN: 0370-0089, 1950 * |
ECKSTEIN, ZYGMUNT: "Synthesis of 6-methoxybenzoxazolone", PRZEMYSL CHEMICZNY , 41(NO. 2), 66-8 CODEN: PRCHAB; ISSN: 0033-2496, 1962 * |
GUILLAUMEL, JEAN ET AL: "Synthesis of 3-chloroindolinones from variously substituted .beta.-nitrostyrenes", JOURNAL OF HETEROCYCLIC CHEMISTRY , 17(7), 1531-6 CODEN: JHTCAD; ISSN: 0022-152X, 1980 * |
MOORE, MAURICE L. ET AL: "Substituted sulfanilamides. III. N4-Acyl-N1-hydroxy derivatives", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY , 62, 2097-9 CODEN: JACSAT; ISSN: 0002-7863, 1940 * |
See also references of WO2008074132A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1973872A1 (en) | 2008-10-01 |
CA2672192A1 (en) | 2008-06-26 |
EP2573069A3 (en) | 2013-05-22 |
JP2014111615A (en) | 2014-06-19 |
KR20090094383A (en) | 2009-09-04 |
AU2007335216A1 (en) | 2008-06-26 |
WO2008074132A1 (en) | 2008-06-26 |
CN101610996A (en) | 2009-12-23 |
AU2007335216C1 (en) | 2014-07-10 |
EP2573069A2 (en) | 2013-03-27 |
MX2009006542A (en) | 2009-06-30 |
AU2007335216B2 (en) | 2013-08-15 |
JP2010513326A (en) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1973872A4 (en) | Inhibitors of histone deacetylase and prodrugs thereof | |
HK1220179A1 (en) | Inhibitors of histone deacetylase | |
EP1991226A4 (en) | Inhibitors of histone deacetylase | |
HK1133199A1 (en) | Histone deacetylase and tubulin deacetylase inhibitors | |
EP2217588A4 (en) | Inhibitors of histone deacetylase | |
IL198263A0 (en) | Hydroxamates as inhibitors of histone deacetylase | |
ZA200906609B (en) | Inhibitors of histone deacetylase | |
HK1142597A1 (en) | Inhibitors of histone deacetylase | |
HK1126769A1 (en) | Benzamide derivatives as inhibitors of histone deacetylase | |
HK1128285A1 (en) | Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase | |
EP1735319A4 (en) | Inhibitors of histone deacetylase | |
EP1755601A4 (en) | Inhibitors of histone deacetylase | |
EP1789381A4 (en) | Inhibitors of histone deacetylase | |
IL193458A0 (en) | Histone deacetylase inhibitors | |
ZA201002841B (en) | Histone deacetylase inhibitors | |
EP2265590A4 (en) | Selective inhibitors of histone deacetylase | |
EP1940805A4 (en) | Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase | |
EP1991247A4 (en) | Bifunctional histone deacetylase inhibitors | |
ZA200800901B (en) | Histone deacetylase inhibitors | |
EP1745022A4 (en) | Histone deacetylase inhibitor prodrugs | |
HK1161583A1 (en) | Deacetylase inhibitors and uses thereof | |
EP2170076A4 (en) | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors | |
EP1771167A4 (en) | Histone deacetylase inhibitors | |
EP2308868A4 (en) | Histone deacetylase inhibitors and uses thereof | |
EP2045239A4 (en) | Novel derivatives of phthalimide as histone deacetylase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080331 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: METHYLGENE INC. |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 333/62 20060101ALI20120327BHEP Ipc: C07D 333/34 20060101ALI20120327BHEP Ipc: C07D 307/54 20060101ALI20120327BHEP Ipc: C07D 285/135 20060101ALI20120327BHEP Ipc: C07C 317/44 20060101ALI20120327BHEP Ipc: C07C 275/42 20060101ALI20120327BHEP Ipc: C07C 259/10 20060101ALI20120327BHEP Ipc: A61P 35/00 20060101ALI20120327BHEP Ipc: A61K 31/435 20060101ALI20120327BHEP Ipc: A61K 31/433 20060101ALI20120327BHEP Ipc: A61K 31/381 20060101ALI20120327BHEP Ipc: A61K 31/34 20060101ALI20120327BHEP Ipc: A61K 31/18 20060101ALI20120327BHEP Ipc: A61K 31/17 20060101ALI20120327BHEP Ipc: A61K 31/16 20060101ALI20120327BHEP Ipc: A61K 31/10 20060101ALI20120327BHEP Ipc: C07C 311/21 20060101AFI20120327BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120411 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20121113 |